Moshe Manor
2017
In 2017, Moshe Manor earned a total compensation of $937.7K as President and Chief Executive Officer at Protalix BioTherapeutics, a 37% increase compared to previous year.
Compensation breakdown
| Bonus | $374,000 |
|---|---|
| Option Awards | $103,354 |
| Salary | $355,290 |
| Other | $105,056 |
| Total | $937,700 |
Manor received $374K in bonus, accounting for 40% of the total pay in 2017.
Manor also received $103.4K in option awards, $355.3K in salary and $105.1K in other compensation.
Rankings
In 2017, Moshe Manor's compensation ranked 9,266th out of 14,666 executives tracked by ExecPay. In other words, Manor earned more than 36.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,266 out of 14,666 | 37th |
Division Manufacturing | 3,559 out of 5,772 | 38th |
Major group Chemicals And Allied Products | 1,223 out of 2,075 | 41st |
Industry group Drugs | 983 out of 1,731 | 43rd |
Industry Biological Products, Except Diagnostic Substances | 175 out of 313 | 44th |
Source: SEC filing on March 6, 2018.
Manor's colleagues
We found four more compensation records of executives who worked with Moshe Manor at Protalix BioTherapeutics in 2017.
2017
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2017
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2017
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2017
Tzvi Palash
Protalix BioTherapeutics